ILEX MEDICAL LTD |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6,699 ILa | -2.45% |
|
-2.26% | +13.93% |
| Sales 2022 | 873M 229M 87.25B 19.11B | Sales 2023 | 931M 245M 93.09B 20.39B | Capitalization | 663M 174M 66.33B 14.53B |
|---|---|---|---|---|---|
| Net income 2022 | 102M 26.81M 10.2B 2.23B | Net income 2023 | 50M 13.14M 5B 1.1B | EV / Sales 2022 | 1.04 x |
| Net cash position 2022 | 174M 45.77M 17.41B 3.81B | Net cash position 2023 | 169M 44.38M 16.88B 3.7B | EV / Sales 2023 | 0.53 x |
| P/E ratio 2022 |
10.6
x | P/E ratio 2023 |
12.9
x | Employees | 223 |
| Yield 2022 |
2% | Yield 2023 |
2.32% | Free-Float | 37.55% |
More Fundamentals
* Assessed data
More news
| 1 day | -2.45% | ||
| 1 week | -2.26% | ||
| Current month | +1.50% | ||
| 1 month | +3.11% | ||
| 3 months | +10.13% | ||
| 6 months | +11.19% | ||
| Current year | +13.93% |
1 week
6 674.00
6 880.00
1 month
6 465.006 952.00
Current year
5 950.006 952.00
1 year
5 352.008 300.00
3 years
5 352.0017 070.00
5 years
5 352.0017 070.00
10 years
1 318.0017 070.00
| Managers | Title | Age | Since |
|---|---|---|---|
Moshe Ben-Shaul
FOU | Founder | 81 | 01/77/01 |
Tamar Galili
CEO | Chief Executive Officer | 51 | 01/92/01 |
| Director of Finance/CFO | 51 | 01/22/01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Lihi Segal
BRD | Director/Board Member | 52 | 21/21/21 |
Moshe Ben-Shaul
FOU | Founder | 81 | 01/77/01 |
Lian Goldstein
BRD | Director/Board Member | 49 | 11/21/11 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25/24/25 | 6,699 | -2.45% | 876 |
| 24/24/24 | 6,867 | +0.19% | 281 |
Delayed Quote TEL AVIV STOCK EXCHANGE, April 25, 2024 at 04:54 pm IST
More quotes
Ilex Medical Ltd is an Israel-based company active in the medical sector. It is a supplier of in vitro diagnostic equipment and laboratory management software. The Company offers cutting-edge diagnostic equipment and reagent systems; nucleic acid testing (NAT) blood screening solutions; products for cancer screening, retro virus load, TB, and STDs, and other infectious diseases; laboratory information systems (LIS); and blood sugar monitoring products. Among the Companyâs subsidiaries and affiliates are Ilex South Africa, Orsyx-LIS, Ilex BioTech Ltd and Medtechnica Ltd.
| 1st Jan change | Capi. | |
|---|---|---|
| +13.93% | 198M | |
| -8.67% | 287M | |
| +26.13% | 77.74M | |
| +20.48% | 65.76M |
- Stock Market
- Equities
- ILX Stock
